JUNB and COVID-19: Notably, the mitogen-activated protein kinase (MAPK) pathway (i.e., FOS, JUN, JUNB, and DUSP1) was greatly suppressed in all recovered patients compared with that in the HCs, which suggested that inhibition of the MAPK signaling pathway is a recovery sign of COVID-19 patient [42].